Vastagbélrák: vizsgálatok itt: Kína
616 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in KínaNeoadjuvant Immunotherapy ± Radiotherapy in MSI-H/dMMR Locally Advanced Colorectal Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 114
- Run by
- Fudan University
See details and how to joinNCT07403877 - 1/2. fázisTaking peopleStudy of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
- Where
- Baoding, Beijing, Bengbu, Cangzhou, Ch’ang-ch’un, Changchun, Changsha, Chengdu, Chifeng, Chongqing, Dalian, Fuzhou, Ganzhou, Guangzhou, Ha’erbin, Hangzhou, Hanzhong, Harbin, Hefei, Henan, Hohhot, Jiangxi, Jilin City, Jinan, Kunming, Lanzhou, Nanchang, Nanjing, Nanning, Nantong, Qingdao, Qinhuangdao, Shanghai, Shantou, Shenyang, Shenzhen, Suzhou, Taiyuan, Taizhou, Tianjin, Tonghua, Weifang, Wenzhou, Wuhan, Wuhu, Xiamen, Xi’an, Xuzhou, Yantai, Yibin, Yinchuan, Zhengzhou, Zhenzhou
- Életkor
- 18 év and over
- People
- 400
- Run by
- Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT04930432 - No phaseTaking peopleValidation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer
- Where
- Guangzhou
- People
- 1000
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07239063 - No phaseTaking peopleAI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 1500
- Run by
- Tongji Hospital
See details and how to joinNCT07399236 - 2. fázisTaking peopleAnlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 37
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT07398326 - No phaseTaking peopleProspective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
- Where
- Shanghai
- Életkor
- 19 hónap to 80 hónap
- People
- 260
- Run by
- Mu-qing Yang
See details and how to joinNCT07177742 - 1/2. fázisNot yet taking people in KínaLPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 99
- Run by
- Luye Pharma Group Ltd.
See details and how to joinNCT07391566 - 2. fázisTaking peopleClinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 583
- Run by
- Chinese PLA General Hospital
See details and how to joinNCT07391618 - No phaseTaking peopleProspective Validation of an AI Model for Predicting Liver Metastasis in Colorectal Cancer
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 160
- Run by
- Tongji Hospital
See details and how to joinNCT07392567 - No phaseNot yet taking people in KínaIntegrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 200
- Run by
- Fudan University
See details and how to joinNCT07391007 - 1. fázisTaking peopleA Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 194
- Run by
- Hefei TG ImmunoPharma Co., Ltd.
See details and how to joinNCT07376707 - No phaseTaking peopleApplication of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
- Where
- Guangzhou, Maoming
- People
- 320
- Run by
- Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT06719414 - No phaseTaking peopleThe Impact of Probiotic Intervention on the Gut Microbiota and Bowel Function
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 156
- Run by
- Huashan Hospital
See details and how to joinNCT07369830 - 2. fázisTaking peopleComparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 100
- Run by
- Fudan University
See details and how to joinNCT07371273 - 3. fázisTaking peopleStudy of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Harbin, Jinan, Kunming, Meizhou, Nanchang, Shanghai, Shenzhen, Taiyuan, Tianjin, Wuhan, Xiamen, Yangzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 892 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05855200 · EU 2023-503265-27-00 - 1. fázisTaking peopleStudy of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
- Where
- Hangzhou
- Életkor
- 18 év and over
- People
- 18
- Run by
- Weijia Fang, MD
See details and how to joinNCT06821048 - 1. fázisTaking peopleFirst in Human Study of SIM0610 in Solid Tumors
- Where
- Chongqing, Harbin, Jinan, Shanghai, Shenyang
- Életkor
- 18 év and over
- People
- 260
- Run by
- Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT07348211 - 2. fázisNot yet taking people in KínaA Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 50
- Run by
- Fudan University
See details and how to joinNCT05954429 - 1/2. fázisNot yet taking people in KínaA Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 126
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT07358585 - No phaseTaking peopleLeucine Plus Radiochemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 80 év
- People
- 33
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07359989 - 3. fázisTaking peopleA Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
- Where
- Fuzhou, Hangzhou, Harbin, Jinan, Nanjing, Tianjin
- Életkor
- 18 év and over
- People
- 464
- Run by
- Jiangsu Simcere Pharmaceutical Co., Ltd.
See details and how to joinNCT07361003 - 2. fázisNot yet taking people in KínaFruquintinib Combined With Trifluridine/Tipiracil Versus Bevacizumab Combined With Trifluridine/Tipiracil for Advanced Metastatic Colorectal Cancer
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 292
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07286695 - 1/2. fázisNot yet taking people in KínaA Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 72
- Run by
- Akeso
See details and how to joinNCT07357220 - 1/2. fázisTaking peopleA Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Haerbin, Hangzhou, Hefei, Langfang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Suzhou, Taiyuan, Tianjin, Wuhan, Xi’an, Zhengzhou
- People
- 334
- Run by
- Jacobio Pharmaceuticals Co., Ltd.
See details and how to joinNCT06959615 - 2. fázisNot yet taking people in KínaPhase Ib/II Study of QL1706 + Fruquintinib + SCRT vs. Standard Third-Line Therapy in Unresectable Liver-Metastatic pMMR/MSS Colorectal Cancer: Safety, Tolerability, and Efficacy.
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 76
- Run by
- Tao Zhang
See details and how to joinNCT07353268